Henry Schein, Inc. logo

Henry Schein, Inc. (HSIC)

Market Closed
12 Aug, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
67. 50
+1.4
+2.12%
Pre Market
$
76. 00
+8.5 +12.59%
7.99B Market Cap
21.94 P/E Ratio
0% Div Yield
2,400,182 Volume
4.54 Eps
$ 66.1
Previous Close
Day Range
66.19 67.87
Year Range
60.56 82.49
Want to track HSIC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 82 days
Should You Retain Henry Schein Stock in Your Portfolio Right Now?

Should You Retain Henry Schein Stock in Your Portfolio Right Now?

Investors are optimistic about HSIC owing to the performance of its dental business.

Zacks | 7 months ago
Here's Why Henry Schein (HSIC) is a Strong Value Stock

Here's Why Henry Schein (HSIC) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks | 8 months ago
Henry Schein (HSIC) Up 6.4% Since Last Earnings Report: Can It Continue?

Henry Schein (HSIC) Up 6.4% Since Last Earnings Report: Can It Continue?

Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock?

Zacks | 8 months ago
Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term

Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks | 8 months ago
Activist Ananym has a list of suggestions for Henry Schein. How the firm can help improve profits

Activist Ananym has a list of suggestions for Henry Schein. How the firm can help improve profits

Ananym Capital is calling for changes at Henry Schein, which may help the company improve its profitability.

Cnbc | 8 months ago
HSIC Stock Likely to Gain From Its Latest Acquisition of Acentus

HSIC Stock Likely to Gain From Its Latest Acquisition of Acentus

Henry Schein inked a new agreement to acquire Acentus to enhance its ability to deliver CGM products directly to patients' homes.

Zacks | 8 months ago
Exclusive: Activist investor Ananym Capital pushes for changes at Henry Schein, sources say

Exclusive: Activist investor Ananym Capital pushes for changes at Henry Schein, sources say

Activist investor Ananym Capital Management is urging healthcare products distributor Henry Schein to refresh its board, cut costs, tackle succession planning and consider selling its medical distribution business, sources close to matter said on Monday.

Reuters | 8 months ago
Dental supply stock rallies on theory RFK's anti-fluoride stance will prompt more dentist visits

Dental supply stock rallies on theory RFK's anti-fluoride stance will prompt more dentist visits

Henry Schein shares climbed more than 4% in Monday trading, on track to notch their best day since July. Financial firm Gordon Haskett said Robert F.

Cnbc | 8 months ago
Henry Schein, Inc. (HSIC) Q3 2024 Earnings Call Transcript

Henry Schein, Inc. (HSIC) Q3 2024 Earnings Call Transcript

Henry Schein, Inc. (NASDAQ:HSIC ) Q3 2024 Earnings Conference Call November 5, 2024 10:00 AM ET Company Participants Graham Stanley - VP, IR & Strategic Financial Project Officer Stanley Bergman - Chairman & CEO Ronald South - SVP and CFO Conference Call Participants Elizabeth Anderson - Evercore ISI Jeffrey Johnson - Baird Kevin Caliendo - UBS Jonathan Block - Stifel Jason Bednar - Piper Sandler John Stansel - JPMorgan Brandon Vazquez - William Blair Michael Petusky - Barrington Research Operator Good morning, ladies and gentlemen, and welcome to Henry Schein's Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.

Seekingalpha | 9 months ago
Henry Schein (HSIC) Reports Q3 Earnings: What Key Metrics Have to Say

Henry Schein (HSIC) Reports Q3 Earnings: What Key Metrics Have to Say

The headline numbers for Henry Schein (HSIC) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Zacks | 9 months ago
HSIC Q3 Earnings Top, Margins Down, Stock Gains in Premarket

HSIC Q3 Earnings Top, Margins Down, Stock Gains in Premarket

Henry Schein's third-quarter results reflect an improvement in sales trends in Technology and Value-Added Services business.

Zacks | 9 months ago
Henry Schein (HSIC) Q3 Earnings Top Estimates

Henry Schein (HSIC) Q3 Earnings Top Estimates

Henry Schein (HSIC) came out with quarterly earnings of $1.22 per share, beating the Zacks Consensus Estimate of $1.16 per share. This compares to earnings of $1.32 per share a year ago.

Zacks | 9 months ago
Loading...
Load More